Você procurou por: cysteamin (Dinamarquês - Inglês)

cysteamin (mercaptaminbitartrat)
cysteamine (mercaptamine bitartrate)

cysteamin kan forårsage sløvhed.
cysteamine may cause drowsiness.

cystagon 150 mg hårde kapsler cysteamin
cystagon 150 mg hard capsules cysteamine

procysbi, enterokapsler, hårde, 25 mg cysteamin
procysbi 25 mg gastro-resistant hard capsules cysteamine

det vides ikke om cysteamin fjernes ved hæmodialyse.
it is not known if cysteamine is removed by haemodialysis.

det er ukendt, om cysteamin fjernes ved hæmodialyse.
it is not known if cysteamine is removed by haemodialysis.

en overdosering med cysteamin kan medføre tiltagende døsighed.
an overdose of cysteamine may cause progressive lethargy.

administration af cysteamin hos nyfødte rotter inducerede katarakter.
administration of cysteamine in neonate rats induced cataracts.

været behandlet med høje doser af forskellige cysteamin formuleringer.
treated with high doses of different cysteamine preparations.

hver hård kapsel indeholder 150 mg cysteamin (som mercaptaminbitartrat).
each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) .

mellem patienterne behandlet med cysteamin blev glomerulær funktion opretholdt.
among cysteamine patients, glomerular function was maintained over time.

cysteamin til oral administration kan ikke forhindre aflejringer af cystinkrystaller i øjet.
oral cysteamine has not been shown to prevent eye deposition of cystine crystals.

hver hård kapsel indeholder 50 mg cysteamin (som mercaptamin bitartrat).
each hard capsule contains 50 mg of cysteamine (as mercaptamine bitartrate) .

hos nyretransplanterede patienter er afstødningshindrende medicin blevet anvendt sammen med cysteamin.
in cases of patients with kidney transplants, anti-rejection treatments have been used with cysteamine.

cysteamin kan medføre godartet forhøjet intrakranielt tryk, også kaldet falsk hjernesvulst.
benign intracranial hypertension, also called pseudotumor cerebri, has been reported with cysteamine use.

hver hård kapsel cystagon 150 mg indeholder 150 mg cysteamin (som mercaptaminbitartrat).
cystagon 50 mg contains 50 mg of cysteamine (as mercaptamine bitartrate) each hard capsule of cystagon 150 mg contains 150 mg of cysteamine (as mercaptamine bitartrate)

så hvor cysteamin optalisk opløsning allerede anvendes mod denne indikation, bør behandlingen fortsætte.
therefore, where cysteamine ophthalmic solution is used for that purpose, its usage should continue.

cysteamin kan give andre symptomer fra tarmene såsom kvalme, opkastning, appetitløshed og mavepine.
other intestinal symptoms including nausea, vomiting, anorexia and stomach ache can occur with cysteamine.

cysteamin reagerer med cystin og danner et sammensat disulfid mellem cysteamin og cystin, og cystin.
cysteamine reacts with cystine to form the mixed disulfide of cysteamine and cysteine, and cysteine.

cysteamin reagerer med cystin og danner cystein og cystein- cysteaminsalt (blandet disulfid).
cystagon reacts with cystine to form cysteine and a cysteine-cysteamine salt (mixed disulfide).